2 Under-the-Radar Pharma M&A Targets for 2018 Post author:Sam Post published:January 10, 2018 Post category:BioPharma A look at why these two biopharma companies could have targets on their backs. Source: BioSpace You Might Also Like Cash-Strapped Alder Biopharma Secures $160 Million in Stock Sale to Continue Operations July 13, 2017 <b>John Adamou</b> Named Vice President Of Corporate & Business Development At <b>rHEALTH</b> And <b>DNA Medicine Institute</b> January 30, 2017 Select Medical Announces Appointment Of To The Board Of Directors February 20, 2017
Cash-Strapped Alder Biopharma Secures $160 Million in Stock Sale to Continue Operations July 13, 2017
<b>John Adamou</b> Named Vice President Of Corporate & Business Development At <b>rHEALTH</b> And <b>DNA Medicine Institute</b> January 30, 2017
